Gene therapy for malignant glioma.

Gene therapy for malignant glioma.

Item
http://www.wikidata.org/entity/Q35673628
Overview of current immunotherapeutic strategies for gliomaDihydropyrimidine Dehydrogenase Is a Prognostic Marker for Mesenchymal Stem Cell-Mediated Cytosine Deaminase Gene and 5-Fluorocytosine Prodrug Therapy for the Treatment of Recurrent Gliomas.Anti-Epidermal Growth Factor Receptor Gene Therapy for GlioblastomaLower MGMT expression predicts better prognosis in proneural-like glioblastomaRecent advances and future of immunotherapy for glioblastoma.Antitumor activity of combined endostatin and thymidine kinase gene therapy in C6 glioma models.Combinatorial therapy with adenoviral-mediated PTEN and a PI3K inhibitor suppresses malignant glioma cell growth in vitro and in vivo by regulating the PI3K/AKT signaling pathway.A hypoxia- and telomerase-responsive oncolytic adenovirus expressing secretable trimeric TRAIL triggers tumour-specific apoptosis and promotes viral dispersion in TRAIL-resistant glioblastoma.Glioblastoma Bystander Cell Therapy: Improvements in Treatment and Insights into the Therapy Mechanisms
P2860

Gene therapy for malignant glioma.

Item
http://www.wikidata.org/entity/Q35673628
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Gene therapy for malignant glioma.
@ast
Gene therapy for malignant glioma.
@en
type
label
Gene therapy for malignant glioma.
@ast
Gene therapy for malignant glioma.
@en
prefLabel
Gene therapy for malignant glioma.
@ast
Gene therapy for malignant glioma.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P478
P577
P5875
P6179
P698
P921
P932
P356
P1433
P1476
Gene therapy for malignant glioma.
@en
P2093
P2860
P2888
P304
P31
P356
P478
P577
P5875
P6179
P698
P921
P932